NCT05059899

Brief Summary

The purpose of the study is to assess the feasibility of undertaking a randomised controlled trial investigating the effectiveness of a 12-week home-based exercise programme for people with intermittent claudication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 28, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

May 9, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2023

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

1.1 years

First QC Date

September 17, 2021

Last Update Submit

August 21, 2023

Conditions

Keywords

home-based exercisecircuit trainingwalking

Outcome Measures

Primary Outcomes (4)

  • Intervention feasibility assessed via recruitment rate

    The investigators will record the number of eligible participants, as well as the number who enroll onto the study.

    Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)

  • Intervention feasibility assessed via attrition rate

    The investigators will record the number of protocol discontinuations and losses to follow-up.

    Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)

  • Intervention feasibility assessed via protocol adherence

    The investigators will examine discrepancies between intervention prescription and what is completed.

    Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)

  • Intervention acceptability via participant interviews

    One-to-one interviews will be held between an investigator and participant who has either completed the intervention, withdrawn or declined participation, to ask questions regarding the intervention protocol.

    Will be evaluated after the intervention period (either at 12 week or 24 week follow up)

Secondary Outcomes (9)

  • 12 and 24 week change in six-minute walk distance and pain-free walk distance

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 week change in pain-free and maximal treadmill walk distance

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 weeks change in left and right hand grip strength (via hand held dynamometer)

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 week change in physical activity measured by accelerometer data

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 week change in SF-36 score

    Baseline to 12 weeks and 24 weeks

  • +4 more secondary outcomes

Other Outcomes (3)

  • 12 and 24 week change in rest times during a six-minute walk test

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 week change in pain cessation following a treadmill test

    Baseline to 12 weeks and 24 weeks

  • 12 and 24 week changes in walking speed during a six-minute walk test

    Baseline to 12 weeks and 24 weeks

Study Arms (2)

Exercise group

EXPERIMENTAL

Home-based circuit and community walking exercise

Behavioral: Exercise group

Usual care

NO INTERVENTION

Usual activity/healthcare

Interventions

Exercise groupBEHAVIORAL

The exercise group will receive a 12-week home-based exercise programme, with a wearable activity watch to regulate physical activity behaviour. This group will also receive biweekly telephone calls from the investigator.

Exercise group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ankle/brachial index (ABPI) \< 0.9 at rest or a drop of 20mmHg after exercise testing
  • Ability to walk independently
  • English speaking
  • Able to follow instructions
  • ≥ 18 years of age

You may not qualify if:

  • Unable to provide informed consent
  • Walking impairment for a reason that is not PAD
  • Critical limb ischaemia
  • Asymptomatic PAD
  • Active cancer treatment
  • Severe mental or physical limitations precluding participation safely in the home environment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Coventry University

Coventry, West Midlands, CV1 2DS, United Kingdom

Location

Related Publications (1)

  • Waddell A, Denton F, Powell R, Broom DR, Birkett ST, McGregor G, Harwood AE. "It's put a routine and regimen in my life" - Participant experiences with a programme of community walking and home-based circuit training for intermittent claudication. J Vasc Nurs. 2024 Dec;42(4):276-281. doi: 10.1016/j.jvn.2024.09.003. Epub 2024 Sep 28.

MeSH Terms

Conditions

Peripheral Arterial DiseaseIntermittent Claudication

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alexander Waddell, MSc

    Coventry University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

September 17, 2021

First Posted

September 28, 2021

Study Start

May 9, 2022

Primary Completion

June 26, 2023

Study Completion

June 26, 2023

Last Updated

August 22, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations